Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 2/1/2026

Guideline Recommendations for Prevention and Management of Catheter‑Associated Urinary Tract Infection (CAUTI) in the ICU

Effectiveness of Drainage‑System Features

  • Complex closed drainage systems with anti‑reflux valves do not reduce catheter‑associated bacteriuria or urinary tract infection; the Infectious Diseases Society of America (IDSA) rates the evidence as level A‑I for bacteriuria and A‑III for infection. 1
  • Only about 7 % of catheter‑associated bacteriuria originates from contamination of the drainage bag, indicating that intraluminal ascent from the bag is uncommon. 5

Positioning of Drainage Bag and Tubing

  • The IDSA strongly recommends that the drainage bag and connecting tube be kept continuously below the level of the bladder to prevent reflux and bacterial ascent; evidence level A‑III. 1
  • Raising the drainage bag above the bladder facilitates bacterial ascent into the catheter system. 5
  • This positioning recommendation applies to both short‑term and long‑term catheterization. 3

Antimicrobial‑Coated (Silver‑Alloy) Catheters

  • Silver‑alloy coated catheters may reduce or delay asymptomatic catheter‑associated bacteriuria; evidence graded B‑II. 1
  • Current data are insufficient to conclude that silver‑alloy catheters decrease the incidence of symptomatic catheter‑associated urinary tract infection. 1
  • In a prospective crossover study of >3,000 patients, silver‑alloy catheters were not identified as an independent protective factor against catheter‑associated bacteriuria in multivariable analysis. 2

Antimicrobial Prophylaxis

  • Routine systemic or intravesical antimicrobial prophylaxis at catheter insertion, removal, or replacement is not recommended; evidence levels A‑I (placement), B‑I (removal), and A‑III (replacement). 5
  • Evidence is insufficient to demonstrate that prophylaxis reduces catheter‑associated bacteremia. 5
  • A Cochrane review found a reduction in bacteriuria with prophylaxis, but studies mainly measured asymptomatic bacteriuria and had heterogeneous outcomes; the clinical benefit for preventing symptomatic infection remains unclear. 6
  • The risk of Clostridioides difficile infection and antimicrobial resistance outweighs the uncertain benefits of routine prophylaxis. 6

Risk Factors

  • Repeat catheterization is an independent risk factor for CAUTI, with an odds ratio of approximately 10 (P < 0.05). 9
  • Duration of catheterization remains the most important risk factor for developing CAUTI. 9